Table 1.
PDB ID | Method | Resolution | Length | Domain | Ligand | Mutations | Ref. |
---|---|---|---|---|---|---|---|
2Z62 | X-ray | 1.70 Å | 27–228 | TLR4-ECD/MD2 | Eritoran | - | [13] |
2Z63 | X-ray | 2.00 Å | 27–527 | TLR4-ECD/MD2 | Eritoran | - | [13] |
2Z65 | X-ray | 2.70 Å | 27–228 | TLR4-ECD/MD2 | Eritoran | - | [13] |
2Z66 | X-ray | 1.90 Å | 381–627 | TLR4-ECD/MD2 | Eritoran | - | [13] |
3FXI | X-ray | 3.10 Å | 27–631 | TLR4-ECD/MD2 | LPS | - | [12] |
3UL7 | X-ray | 2.37 Å | 28–226 | TLR4-ECD | - | F63W | [50] |
3UL8 | X-ray | 2.50 Å | 27–228 | ECD | - | V134L | [50] |
3UL9 | X-ray | 2.45 Å | 28–228 | ECD | - | M141E | [50] |
3ULA | X-ray | 3.60 Å | 27–228 | ECD | - | F63W | [50] |
4G8A | X-ray | 2.40 Å | 23–629 | TLR4-ECD/MD2 | LPS | D299G/T399I | [51] |
5NAM | NMR | - | 623–670 | TM Domain | - | - | [17] |
5NAO | NMR | - | 623–657 | TM Domain | - | - | [17] |